Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer
|ClinicalTrials.gov Identifier: NCT01049295|
Recruitment Status : Unknown
Verified April 2011 by Zohreh Ghoreishi, Tehran University of Medical Sciences.
Recruitment status was: Recruiting
First Posted : January 14, 2010
Last Update Posted : November 1, 2011
Tehran University of Medical Sciences
Information provided by (Responsible Party):
Zohreh Ghoreishi, Tehran University of Medical Sciences
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||November 2011|
|Estimated Study Completion Date :||February 2012|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Ghoreishi Z, Esfahani A, Djazayeri A, Djalali M, Golestan B, Ayromlou H, Hashemzade S, Asghari Jafarabadi M, Montazeri V, Keshavarz SA, Darabi M. Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial. BMC Cancer. 2012 Aug 15;12:355.